Dose assessment to the Bladder during Intracavitary Brachytherapy of the Cervix using Gafchromic films

Author(s):  
J. Avevor ◽  
S. N. A. Tagoe ◽  
J. H. Amuasi ◽  
J. J. Fletcher ◽  
I. Shirazu

Intracavitary brachytherapy procedures are used for cervical cancer treatment, by the insertion of radioactive implants directly into the diseased tissues. During the treatment process, the bladder together with surrounding tissues are exposed to radiations. Clinical complications do results from high doses received by parts of the bladder during intracavitary brachytherapy of the cervix. The aim of this study is to assess the dose delivered to the bladder using Gafchromic films and compare it with the optimized dose calculated by the Brachy Prowess 4.60 Treatment Planning System (TPS) reports for empirical validation and system verification. Fletcher suite applicators were used to perform thirty (30) different clinical insertions on the constructed cervix phantom and results evaluated. The mean difference between the doses calculated by the TPS and the doses measured by the Gafchromic film for the bladder at the distance of 0.5cm from the edge of the film was 16.3 % (range -35.33 to +39.37). At a distance of 1.5cm for the bladder, the mean difference was 19.4% (range -49.48 to +30.39). The TPS calculated maximum dose was typically higher than the measured maximum dose. However, in some cases, the measured doses were found to be higher than the doses calculated by the TPS. This is due to positional inaccuracies of the sources during treatment planning. It is recommended that in vivo dosimetry be performed in addition to computation.

Author(s):  
J. Avevor ◽  
S. N. A Tagoe ◽  
J. H. Amuasi ◽  
J. J. Fletcher ◽  
I. Shirazu

Internal radiation therapy, refers to as brachytherapy, involve putting a source of radiation with high photon in or near a cancerous tissues. The type of brachytherapy used most often to treat cervical cancer is known as intracavitary brachytherapy. Unfortunately however, the radiation source placed in the cervix irradiate the normal tissues of rectum and other nearby organs during intracavitary brachytherapy of the cervix treatment. This high doses received by parts of the rectum is a concern for clinicians and the general public. The aim of this study is to assess the dose delivered to the rectum using Gafchromic films and compare it with the optimized dose calculated by the Brachy Prowess 4.60 Treatment Planning System (TPS) reports for empirical validation and system verification. Fletcher suite applicators were used to perform thirty (30) different clinical insertions on the constructed cervix phantom and results evaluated. The mean difference between the doses calculated by the TPS and the doses measured by the Gafchromic film for the rectum at the distance of 0.5cm from the edges of the film was 23.1% (range -42.42 to +40.41). At a distance of 1.5cm for the rectum the mean was 22.5% (range -49.45 to +46.48). The TPS calculated maximum dose was typically higher than the measured maximum dose. However, in some cases, the measured doses were found to be higher than the doses calculated by the TPS. This is due to positional inaccuracies of the sources during treatment planning. It is recommended that in vivo dosimetry should be performed in addition to computation.


2013 ◽  
Vol 4 (1) ◽  
pp. 43-49
Author(s):  
M Jahangir Alam ◽  
Syed Md Akram Hussain ◽  
Kamila Afroj ◽  
Shyam Kishore Shrivastava

A three dimensional treatment planning system has been installed in the Oncology Center, Bangladesh. This system is based on the Anisotropic Analytical Algorithm (AAA). The aim of this study is to verify the validity of photon dose distribution which is calculated by this treatment planning system by comparing it with measured photon beam data in real water phantom. To do this verification, a quality assurance program, consisting of six tests, was performed. In this program, both the calculated output factors and dose at different conditions were compared with the measurement. As a result of that comparison, we found that the calculated output factor was in excellent agreement with the measured factors. Doses at depths beyond the depth of maximum dose calculated on-axis or off-axis in both the fields or penumbra region were found in good agreement with the measured dose under all conditions of energy, SSD and field size, for open and wedged fields. In the build up region, calculated and measured doses only agree (with a difference 2.0%) for field sizes > 5 × 5 cm2 up to 25 × 25 cm2. For smaller fields, the difference was higher than 2.0% because of the difficulty in dosimetry in that region. Dose calculation using treatment planning system based on the Anisotropic Analytical Algorithm (AAA) is accurate enough for clinical use except when calculating dose at depths above maximum dose for small field size.DOI: http://dx.doi.org/10.3329/bjmp.v4i1.14686 Bangladesh Journal of Medical Physics Vol.4 No.1 2011 43-49


2021 ◽  
Vol 2021 ◽  
pp. 1-9
Author(s):  
Yongdong Zhuang ◽  
Yaoqin Xie ◽  
Luhua Wang ◽  
Shaomin Huang ◽  
Li-Xin Chen ◽  
...  

Purpose. A recurrent neural network (RNN) and its variants such as gated recurrent unit-based RNN (GRU-RNN) were found to be very suitable for dose-volume histogram (DVH) prediction in our previously published work. Using the dosimetric information generated by nonmodulated beams of different orientations, the GRU-RNN model was capable of accurate DVH prediction for nasopharyngeal carcinoma (NPC) treatment planning. On the basis of our previous work, we proposed an improved approach and aimed to further improve the DVH prediction accuracy as well as study the feasibility of applying the proposed method to relatively small-size patient data. Methods. Eighty NPC volumetric modulated arc therapy (VMAT) plans with local IRB’s approval in recent two years were retrospectively and randomly selected in this study. All these original plans were created using the Eclipse treatment planning system (V13.5, Varian Medical Systems, USA) with ≥95% of PGTVnx receiving the prescribed doses of 70 Gy, ≥95% of PGTVnd receiving 66 Gy, and ≥95% of PTV receiving 60 Gy. Among them, fifty plans were used to train the DVH prediction model, and the remaining were used for testing. On the basis of our previously published work, we simplified the 3-layer GRU-RNN model to a single-layer model and further trained every organ at risk (OAR) separately with an OAR-specific equivalent uniform dose- (EUD-) based loss function. Results. The results of linear least squares regression obtained by the new proposed method showed the excellent agreements between the predictions and the original plans with the correlation coefficient r = 0.976 and 0.968 for EUD results and maximum dose results, respectively, and the coefficient r of our previously published method was 0.957 and 0.946, respectively. The Wilcoxon signed-rank test results between the proposed and the previous work showed that the proposed method could significantly improve the EUD prediction accuracy for the brainstem, spinal cord, and temporal lobes with a p value < 0.01. Conclusions. The accuracy of DVH prediction achieved in different OARs showed the great improvements compared to the previous works, and more importantly, the effectiveness and robustness showed by the simplified GRU-RNN trained from relatively small-size DVH samples, fully demonstrated the feasibility of applying the proposed method to small-size patient data. Excellent agreements in both EUD results and maximum dose results between the predictions and original plans indicated the application prospect in a physically and biologically related (or a mixture of both) model for treatment planning.


Author(s):  
Jacek Wendykier ◽  
Aleksandra Grządziel ◽  
Barbara Bekman ◽  
Marcin Bieniasiewicz ◽  
Adam Bekman ◽  
...  

Author(s):  
Dominika Plaza ◽  
Agnieszka Baic ◽  
Barbara Lange ◽  
Agata Stanek ◽  
Krzysztof Ślosarek ◽  
...  

The study is focused on correlation of isotherms derived from thermal images with an isodoses describing treatment plan for patients with breast cancer treated by radiotherapy. The irradiated area covered the part of the body after mastectomy. The study included patients diagnosed with breast cancer who were qualified for radiotherapy treatment. All patients were monitored during each treatment week during the entire radiotherapy process. The measurements were made under strictly defined conditions. In the treatment planning system (TPS), the specific plan was created for each patient. Spatial dose distribution in the patient’s body was obtained and presented by the isodoses (lines connecting points with the same dose values). The following areas from the treatment planning system were plotted on the thermograms: target (tumor area) and isodose: 45 Gy, 40 Gy, 30 Gy, 20 Gy and 10 Gy. The obtained results indicated a high correlation between magnitude of the dose represented as the isodose and the temperature of the treated skin. Moreover, preliminary analysis showed a repeatable increase of the mean temperature in the irradiated area during the treatment.


2013 ◽  
Vol 40 (6Part14) ◽  
pp. 263-264 ◽  
Author(s):  
C Nelson ◽  
S Davidson ◽  
B Mason ◽  
S Kirsner

2019 ◽  
Vol 18 (03) ◽  
pp. 251-261
Author(s):  
Noureddine Slassi ◽  
Hmad Ouabi ◽  
Naïma El Khayati

AbstractAimThe treatment planning system (TPS) plays a key role in radiotherapy treatments; it is responsible for the accurate determination of the monitor unit (MU) needed to be delivered to treat a patient with cancer. The main goal of radiotherapy is to sterilise the tumour; however, any imprecise dose delivered could lead to deadly consequences. The TPS has a quality assurance tool, an independent program to double check the MU, evaluate patient plan correctness and search for any potential error.Materials and methodsIn this work, a comparison was carried out between a MU calculated by TPS and an independent in-house-developed monitor unit calculation program (MUCP). The program, written in Cplusplus (C++ Object-Oriented), requires a database of several measured quantities and uses a recently developed physically based method for field equivalence calculation. The ROOT CERN data analysis library has been used to establish fit functions, to extend MUCP use to a variety of photon beams. This study presents a new approach to checking MU correctness calculated by the TPS for a water-like tissue equivalent medium, using our MUCP, as the majority of previous studies on the MU independent checks were based on the Clarkson method. To evaluate each irradiated region, four calculation points corresponding to relative depths under the water phantom were tested for several symmetric, asymmetric, irregular symmetric and asymmetric field cases. A comparison of MU for each radiation fields from readings of the TPS and the MUCP was undertaken.ResultsA satisfactory agreement has been obtained and within the required standards (3%). Additional experimental measurements of dose deposited in a water phantom showed a deviation of &lt;1·6%.FindingsThe MUCP is a useful tool for basic and complex MU verification for 3D conformal radiation therapy plans.


2013 ◽  
Vol 38 (1) ◽  
pp. 100-104 ◽  
Author(s):  
Slaven Jurković ◽  
Manda Švabić ◽  
Ana Diklić ◽  
Đeni Smilović Radojčić ◽  
Dea Dundara ◽  
...  

Nukleonika ◽  
2021 ◽  
Vol 66 (2) ◽  
pp. 47-53
Author(s):  
Edyta Dąbrowska-Szewczyk ◽  
Anna Zawadzka ◽  
Beata Brzozowska ◽  
Agnieszka Walewska ◽  
Paweł Kukołowicz

Abstract Purpose According to the available international recommendations, at least one independent verification of the calculations of number of monitor unit (MU) is required for every patient treated by teleradiotherapy. The aim of this study was to estimate the differences of dose distributions calculated with two treatment planning systems: Eclipse (Varian) and Oncentra MasterPlan (Elekta). Materials and methods The analysis was performed for 280 three-dimensional conformal radiotherapy treatment (3D-CRT) plans with photon beams from Varian accelerators: CL 600C/D X6 MV (109 plans), CL 2300C/D X6 MV (43 plans), and CL 2300C/D X15 MV (128 plans). The mean doses in the planning target volume (PTV) and doses at the isocenter point obtained with Eclipse and Oncentra MasterPlan (OMP) were compared with Wilcoxon matched-pairs signed rank test. Additionally, the treatment planning system (TPS) calculations were compared with dosimetric measurements performed in the inhomogeneous phantom. Results Data were analysed for 6 MV plans and for 15 MV plans separately, independently of the treatment machine. The dose values calculated in Eclipse were significantly (p <0.001) higher compared to calculations of OMP system. The average difference of the mean dose to PTV was (1.4 ± 1.0)% for X6 MV and (2.5 ± 0.6)% for X15 MV. Average dose disparities at the isocenter point were (1.3 ± 1.9)% and (2.1 ± 1.0)% for X6 MV and X15 MV beams, respectively. The largest differences were observed in lungs, air cavities, and bone structures. Moreover the variation in dosimetric measurements was less as compared to Eclipse calculations. Conclusions OMP calculations were introduced as the independent MU verification tool with the first action level range equal to 3.5%.


Sign in / Sign up

Export Citation Format

Share Document